Amazfit Introduces T-Rex Dual Solar, the First AMOLED Smartwatch with Dual-Sided Solar Charging

Amazfit, a leading global smart wearable brand owned by Zepp Health, today announced the T-Rex Dual Solar , a premium expedition smartwatch built for long-distance and multi-day exploration. Launching on the autumnal equinox — a day defined by the balance of sunlight and darkness — the T-Rex Dual Solar is the world’s first AMOLED smartwatch featuring a dual-sided solar charging system, combining solar...
Anglais

Saildrone USVs Receive Danish Flag Registration for European Operations

Saildrone today announcedthat the first four Saildrone Voyager USVs (unmanned surface vehicles) have been registered in Denmark and will operate under the Danish flag, marking the first time Saildrone USVs...
Anglais

NIQ Announces Friendly Bid to Acquire The U Group & Co Limited, Expanding Trusted Intelligence for the AI Era

NielsenIQ (NYSE: NIQ), a leading consumer intelligence company, today announced that its wholly-owned Australian subsidiary, Nielsen Connect Australia Pty Ltd (NIQ Australia) has launched a conditional off-market offer for all outstanding shares of The U Group & Co Limited (The U Group) as a friendly takeover bid (Offer). The U Group is an Australian-based company specializing in first-party, consumer-consented purchase...
Anglais

OKX Sets a New Standard for Account Protection with OKX Shield

OKX, a leading global cryptocurrency exchange and onchain technology company with more than 150 million customers worldwide, today launched OKX Shield. OKX Shield is an integrated security product suite combining sophisticated safeguards, visible protection status and the potential for customers to be paid...
Anglais
09/22/2026 12:00
Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE Trial

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive results from the Phase 2b AMPLIFIED study of inaxaplin in people with APOL1-mediated kidney disease (AMKD) and modest proteinuria and in people with AMKD and type 2 diabetes. In this study, inaxaplin was evaluated as a 45 mg once-daily dose on top of optimized standard of care. Forty-one people were enrolled and dosed in two cohorts: 1) people with AMKD with modest proteinuria (UACR ≥0.1 g/g to <0.42 g/g) were elig...

09/22/2026 12:00
INNIO Receives Credit Rating Upgrades and Reaffirms Financial Policy to Support Profitable Growth

INNIO N.V. (Nasdaq: INIO) (“INNIO” or the “Company”) today announced that Fitch Ratings has upgraded the Company’s credit ratings, following a recent upgrade by Moody’s Ratings. INNIO also reaffirmed its financial policy framework, which supports investment in profitable growth while continuing to strengthen the Company’s balance sheet. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260922051908/en/INNIO Receives Credit Rating Upgra...

Subscribe to